Skip to main content

Medical Facilities Corporation Renews Normal Course Issuer Bid

Newswire.ca - Thu Nov 27, 2025

TORONTO, Nov. 27, 2025 /CNW/ - Medical Facilities Corporation ("Medical Facilities" or the "Corporation") (TSX: DR), announced today that the Toronto Stock Exchange has approved its notice of intention to make a normal course issuer bid ("NCIB") for up to 1,805,324 of its 18,053,349 outstanding common shares ("Common Shares"), representing 10% of the Corporation's public float of 18,053,249 Common Shares as of November 18, 2025. The Corporation may purchase the Common Shares at prevailing market prices during the period from December 1, 2025, to November 30, 2026, through the facilities of the Toronto Stock Exchange, other designated exchanges and/or alternative Canadian trading systems in accordance with applicable regulatory requirements. Purchases will be made at market prices in accordance with the rules and policies of the Toronto Stock Exchange. Purchases may also be made by such other means as may be permitted by the Toronto Stock Exchange or a securities regulatory authority, including by private agreements under issuer bid exemption orders issued by securities regulatory authorities which shall not be greater than the prevailing market price. Subject to the Toronto Stock Exchange's block purchase exceptions, daily purchases will be limited to 5,569 Common Shares on any trading day, representing 25% of the average daily trading volume of 22,277 Common Shares for the past six months. All securities purchased by Medical Facilities under the normal course issuer bid will be cancelled. As of November 18, 2025, Medical Facilities repurchased 1,973,000 of its Common Shares for a volume-weighted average price of $15.35 under its prior normal course issuer bid for up to 2,339,066 Common Shares, which commenced on December 1, 2024, and expires on November 30, 2025.

Read more at newswire.ca

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.